April Group designs, sells and manages insurance products through distributors, managers, insurers and reinsurers. Co. divides its activities into four divisions: Health and Personal Protection, Property and Casualty, International (mobility/assistance) and Protection and Legal Services. Health and Personal Protection designs, manages and distributes individual and collective policies; Property and Casualty designs, manages and distributes property and casualty policies for individual clients; International division (mobility/assistance) designs, manages, and distributes policies for individuals and businesses settled abroad; and Protection and Legal Services focuses of legal activities.
  • TickerAPR
  • ISINFR0004037125
  • ExchangeEuronext Paris
  • SectorNonlife Insurance
  • CountryFrance

Analysts

1 director sold

A director at April Group sold 26,639,922 shares at 21.600EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of boa...

Benoit Valleaux

April : Transfer of the stake owned by Evolem, offer expected to be launched in the near future

>Evolem’s stake was transferred yesterday at € 21.6 per share - April Group announced yesterday that Evolem’s majority stake in April was transferred yesterday to Andromeda Investissements, a holding company indirectly owned by funds managed by CVC Capital Partners (CVC Fund VII). The transfer price was € 21.60 per share. The price, pursuant to the agreement reached last January, includes two downward adjustments for: 1/ the dividend for 2018, which has been paid, of ...

Benoit Valleaux

April : Transfert de la participation détenue par Evolem, lancement attendu de l’offre prochainement

>La participation d’Evolem a été transférée hier à 21.6 € par action - April Group a indiqué que la participation majoritaire d’Evolem dans April avait été transférée hier à Andromeda Investissements, qui est une société de reprise indirectement détenue par des fonds gérés par CVC Capital Partners (CVC Fund VII). Le prix de transfert a été de 21.60 € par action. Ce prix, conformément à l’accord conclu en janvier dernier, inclut deux ajustements à la baisse : 1/ le div...

Benoit Valleaux

April : Favourable momentum in EBIT in 2018, pending the bid

>Current EBIT growth of 12% in 2018 - On Wednesday evening, April reported its 2018 net income figures and the financial presentation was held on Thursday. The group had reported its 2018 sales figures some weeks earlier. They weighed in at € 997.2m, up 7.4% on a reported basis (+5.4% l-f-l), with a 4.9% increase in commissions (+7.9% in health & personal protection and -0.7% in property & casualty).Current EBIT in 2018 came to € 77.8m, up 12.2%, higher than fore...

Benoit Valleaux

April : 2018 sales and signature of an acquisition contract on the transfer Evolem’s stake in CVC

>A 1.5% increase in commissions on a l-f-l basis in 2018 - Yesterday evening April published its 2018 sales, which came in at € 997.2m, up 7.4% (+5.4% l-f-l), with a 4.9% increase in brokerage commissions on a reported basis and +1.5% l-f-l to € 536m, whilst insurance premiums were up 10.5% to € 460.6m. We had forecast sales of € 1,001.6m with an estimate that was shade above for P&C insurance.In health & personal protection, commissions were up 2.6% l-f-l with g...

Benoit Valleaux

April : CA 2018 et signature d’un contrat d’acquisition concernant le transfert de la participation d’Evolem à CVC

>Hausse des commissions de 1,5% à données comparables en 2018 - April a communiqué hier soir sur son CA 2018, qui ressort à 997,2 M€ en hausse de 7,4% (+5,4% à données comparables), avec une augmentation des commissions de 4,9% en publié et de 1,5% à d.c. à 536,8 M€, alors que les primes d’assurance ont progressé de 10,5% à 460,6 M€. Nous attendions un CA de 1 001,6 M€, avec une prévision de CA légèrement supérieure en assurance dommages.En Santé-Prévoyance, les ...

1 director sold

A director at April Group sold 26,639,922 shares at 21.600EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of boa...

Benoit Valleaux ...
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Geoffroy Michalet
  • Jean-François Granjon
  • Martial Descoutures
  • Pierre Corby
  • Sven Edelfelt
  • Virginie Rousseau

ODDO BHF Small & MIDCAP MORNING NEWS - 06/14/2019

...

Benoit Valleaux ...
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Geoffroy Michalet
  • Jean-François Granjon
  • Martial Descoutures
  • Pierre Corby
  • Sven Edelfelt
  • Virginie Rousseau

ODDO BHF Small & MIDCAP MORNING NEWS - 14/06/2019

...

Benoit Valleaux ...
  • Martial Descoutures
  • Pierre Corby

ODDO BHF Small & MIDCAP MORNING NEWS - 03/11/2019

...

Benoit Valleaux ...
  • Martial Descoutures
  • Pierre Corby

ODDO BHF Small & MIDCAP MORNING NEWS - 11/03/2019

...

Alain William ...
  • Aurelien Sivignon
  • Benoit Valleaux
  • Charles Lepetitpas
  • Jeremy Garnier
  • Nicolas David
  • Oussema Denguir
  • Pierre Corby

ODDO BHF Small & MIDCAP MORNING NEWS - 01/30/2019

...

APRIL suffers a double requalification, which weighs heavily on its rating, now at Slightly Negative.

The independent financial analyst theScreener just downgraded the general evaluation of APRIL (FR), active in the Insurance Brokers industry. As regards its fundamental valuation, the title loses a star(s) and now shows 0 out of 4 stars. Its market behaviour is also negatively reassessed and may be considered as moderately risky. theScreener believes that this double requalification keeps the title under pressure and justifies an overall rating downgrade to Slightly Negative. As of the analysis date September 5, 2017, the closing price was EUR 13.25 and its target price was estimated at EUR 12...

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

MarketLine Department

AXA SA - Strategy, SWOT and Corporate Finance Report

Summary AXA SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights AXA SA (AXA) is an insurance company, offering both life and non-life insurance products. It offers life insurance and savings products such as individual life insurance, group life insurance, health and personal protection products, and individual and group savings retirement products. It also offer...

MarketLine Department

AXA SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

Summary Marketline's AXA SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by AXA SA since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Key Highlights This repo...

Florian Béchaz

April - Assemblée Général des actionnaires du 25 avril 2019

Nous attirons votre attention sur le fait que le 28 janvier 2019, Evolem et CVC Capital Partners ont annoncés rentrer en négociation exclusive en vue du transfert de la participation d'Evolem, détenant 65,13% du capital, au bénéfice d'Andromeda Investissements, une société de reprise contrôlée par des fonds gérés par CVC Capital Partners et dans laquelle Evolem et le management d'APRIL détiendront une part minoritaire. La société annonce que: "le transfert de bloc majoritaire se ferait au prix de 22€ par action APRIL, soit une prime de 27,2 % par rapport au dernier cours de clôture avant l'an...

Jehanne Leroy

Etude de l'AG du 04/05/2017

Proxinvest souhaite attirer l'attention des actionnaires sur la décision du Conseil d'administration de dissocier les fonctions de Président du Conseil d'administration et de Directeur Général. Proxinvest recommande en effet la dissociation des fonctions au sein des organes de direction. Dès lors, Proxinvest accueille très favorablement cette décision. Cependant, Proxinvest déplore le manque de transparence de la société concernant les politiques de rémunérations du Président et du Directeur Général. En effet, telles qu'elles sont présentées, ces politiques ne correspondent pas aux pratiques d...

SRI Quantitative KPIs

Les analyses Gaïa sont des analyses ESG (Environnement, Social, Gouvernance) dediees aux entreprises de tailles intermediaires (PME, ETI) françaises. Elles presentent 120 indicateurs quantitatifs sur les trois derniers exercices.

Jérôme VINERIER

Analyse court terme - APRIL GROUP : La progression des cours se poursuit.

La tendance est haussière. La progression des cours se poursuit. Les objectifs sont à 18,26 € puis 19,50 €. La rupture de 14,20 € mettrait la tendance en danger.

Jérôme VINERIER

Short term view - APRIL GROUP : Prices are making further progress.

The trend is bullish. Prices are making further progress. The targets are at €18.26 and then €19.50. The break of €14.20 would endanger the trend.

Matthieu DRIOL

Short term view - APRIL GROUP : The trend is bullish.

The trend is bullish. Prices are making further progress. The targets are at €15.62 and then €16.10. The break of €12.30 would endanger the trend.

Matthieu DRIOL

Analyse court terme - APRIL GROUP : La tendance est haussière.

La tendance est haussière. La progression des cours se poursuit. Les objectifs sont à 15,62 € puis 16,10 €. La rupture de 12,30 € mettrait la tendance en danger.

Matthieu DRIOL

Analyse court terme - APRIL GROUP : La tendance de fond est clairement orientée à la baisse.

La tendance de fond est clairement orientée à la baisse. Les prix baissent à nouveau, mais le mouvement est devenu hésitant. Le prochain support est à 13,20 €. La tendance de fond serait remise en cause en cas de franchissement de 16,10 €.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch